Sulzderma Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 22 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.60 M
- Revenue Growth 26.46%
- Profit Growth -7.69%
- Ebitda 1082.27%
- Net Worth 3.46%
- Total Assets 6.42%
About Sulzderma Pharmaceuticals
Sulzderma Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 April 2002 and has a history of 22 years and ten months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.60 M.
Vijay Kariwala and Puja Kariwala serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2002PTC135416
-
Company No.
135416
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Apr 2002
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Sulzderma Pharmaceuticals Private Limited offer?
Sulzderma Pharmaceuticals Private Limited offers a wide range of products and services, including Bath Soaps, Ketoconazole Soap, Antifungal Cream, Ointment & Powder, Luliconazole Cream, Anti Acne Drug, Isotretinoin Capsules, Terbinafine Hydrochloride Cream, Skin Ointment, Allantoin Ointment, Pharmaceutical Capsules.
Who are the key members and board of directors at Sulzderma Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Kariwala
|
Director | 04-Apr-2002 | Current |
|
Puja Kariwala
|
Director | 04-Apr-2007 | Current |
Financial Performance of Sulzderma Pharmaceuticals.
Sulzderma Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 26.46% increase. The company also saw a slight decrease in profitability, with a 7.69% decrease in profit. The company's net worth moved up by a moderate rise of 3.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sulzderma Pharmaceuticals?
In 2019, Sulzderma Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.60 M
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Aug 2008 | Union Bank Of India | ₹0.50 M | Open |
| 14 Feb 2006 | Union Bank Of India | ₹0.10 M | Open |
How Many Employees Work at Sulzderma Pharmaceuticals?
Unlock and access historical data on people associated with Sulzderma Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sulzderma Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sulzderma Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.